Mount Sinai Researchers First to Identify That Two Separate Eye Diseases May Contribute to Common Blinding Eye Condition

Two separate eye diseases may contribute to age-related macular degeneration (AMD), a leading cause of blindness in the United States, according to a new study from New York Eye and Ear Infirmary of Mount Sinai.

High-Tech Imaging Offers New Way to Detect Signs of Early Glaucoma

Mount Sinai study shows flavoprotein fluorescence could serve as new biomarker

Henry Ford Health Receives $2M Philanthropic Gift from A.A. Van Elslander Foundation

Henry Ford Health has received a $2 million gift from the A.A. Van Elslander Foundation to establish the Philip C. Hessburg, M.D. – Art Van Elslander Chair in Ophthalmic Research, which will constitute a permanent endowment fund to support the educational research initiatives at Henry Ford Health by the Detroit Institute of Ophthalmology (DIO).

Blinding Eye Disease Is Strongly Associated With Heart Disease and Stroke

Patients with a specific form of age-related macular degeneration (AMD), a leading cause of blindness in the United States, are at significant risk for cardiovascular disease and stroke, according to new research from New York Eye and Ear Infirmary of Mount Sinai.

High Caffeine Consumption may be Associated with Increased Risk of Blinding Eye Disease

Frequent caffeine intake could more than triple risk of glaucoma for those genetically predisposed to higher eye pressure

The Eye, The Brain & The Auto: Call for Research Abstracts from Healthcare and Automotive Experts

The Detroit Institute of Ophthalmology, the research arm of the Henry Ford Health System Department of Ophthalmology, is accepting abstracts for The Eye, The Brain & The Auto 9th World Research Congress on Health and Modern Mobility: Autonomous Vehicles, Driver’s Fitness to Function, and Naturalistic Driving Methods to be held Dec. 7-8, 2020. This will be a virtual event.

Potential Way to Halt Blinding Macular Degeneration Identified

It would be the first treatment for “dry” age-related macular degeneration and could significantly improve treatment for wet AMD.